Online / Physical Event

14th Edition of International conference on

Infectious Diseases

Theme: Latest advances in the field of Global infectious Diseases and Treatment

Event Date & Time

Event Location

Madrid, Spain

Program Abstract Registration Awards 2020

18 years of lifescience communication

Performers / Professionals From Around The Globe

Tracks & Key Topics

Academic Key Topics

More

Business Key Topics

More

infectious deseases 2021

About Conference

20th Edition of International Conference on Infectious Diseases held on November 24-25, 2021, will provide all the attendees, the opportunity to network with experts, present their research findings to an international audience and notify the latest scientific developments from world’s eminent speakers and contribute to various discussions that will shape future health policies and a proper patient care all around the world.

The Conference will have a mix of lectures of keynote addresses, panel discussions, case discussions, current reports of scientific progress featured in oral abstracts and posters. The chosen topics will be of great benefit to practicing clinicians and academicians in the field of infectious diseases, medicine, microbiology, epidemiology, public health, critical care, pulmonology, pharmacology, pathology, pharmacy, nursing, and clinical research. This conference offers an opportunity for faculty, postgraduates, fellows, residents, and undergraduates to present their work, learn and network with the experts. The Infection Control conference hosting presentations from editors of eminent refereed journals, renowned and active investigators and decision makers in the field of infectious diseases, microbiology, immunology, infection control and prevention. Infection control 2020 Organizing Committee also invites young investigators at each and every career stage to submit abstracts reporting their latest scientific researches in oral and poster sessions

 

Session And Tracks

Track 1: Coronavirus (Covid-19)

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It was first identified in December 2019 in Wuhan, China, and has resulted in an ongoing pandemic. The first case may be traced back to 17 November 2019. As of 10 June 2020, more than 7.24 million cases have been reported across 188 countries and territories, resulting in more than 411,000 deaths. More than 3.37 million people have recovered. Common symptoms include fever, cough, fatigue, shortness of breath, and loss of smell and taste. While the majority of cases result in mild symptoms, some progress to acute respiratory distress syndrome (ARDS) likely precipitated by a cytokine storm, multi-organ failure, septic shock, and blood clots

Track 2: Global Infectious Diseases

Globalization, the flow of information, goods, capital, and people across political and geographic boundaries, allows infectious diseases to rapidly spread around the world, while also allowing the alleviation of factors such as hunger and poverty, which are key determinants of global health. The spread of diseases across wide geographic scales has increased through history. Early diseases that spread from Asia to Europe were bubonic plague, influenza of various types, and similar infectious diseases.

Track 3: Research on Medicine and Vaccine for covid-19

COVID-19 vaccine is a hypothetical vaccine against coronavirus disease 2019 (COVID‑19). Although no vaccine has completed clinical trials, there are multiple efforts in progress to develop such a vaccine. In February 2020, the World Health Organization (WHO) said it did not expect a vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative virus, to become available in less than 18 months. Previous attempts to develop a vaccine against the coronavirus diseases, SARS and MERS, established considerable knowledge about the structure and function of coronaviruses – which accelerated rapid development during early 2020 of varied technology platforms for a COVID-19 vaccine

Track 4: Host Microbial Genetics

Microbial genetics is a subject area within microbiology and genetic engineering. Microbial genetics studies microorganisms for different purposes. The microorganisms that are observed are bacteria, and archaea. Some fungi and protozoa are also subjects used to study in this field. The studies of microorganisms involve studies of genotype and expression system. Genotypes are the inherited compositions of an organism. (Austin, "Genotype," n.d.) Genetic Engineering is a field of work and study within microbial genetics. The usage of recombinant DNA technology is a process of this work

Track 5: Pediatric Infectious Diseases and Allergy

Paediatric infectious diseases/ childhood infectious diseases are the infectious diseases which are caused in children of diverse age groups. Infection from mother to foetus, in just born babies and children is growing danger. The death rates are increasing due to infections. The epidemiological features of congenital and neonatal diseases due to bacterial, viral, vector-borne infections despite become more threat.

Track 6: Zoonotic Diseases

A zoonosis plural zoonoses, or zoonotic diseases is an infectious disease caused by a pathogen (an infectious agent, such as a bacterium, virus, parasite or prion) that has jumped from a non-human animal (usually a vertebrate) to a human. Typically, the first infected human transmits the infectious agent to at least one other human, who, in turn, infects others. Major modern diseases such as Ebola virus disease and salmonellosis are zoonoses

Track 7: Clinical Immunology

Immunology is a branch of biology that covers the study of immune systems in all organisms. Immunology charts, measures, and contextualizes the physiological functioning of the immune system in states of both health and diseases; malfunctions of the immune system in immunological disorders (such as autoimmune diseases, hypersensitivities, immune deficiency, and transplant rejection

Track 8: Anti-microbial agents

Antimicrobials are the drugs used in the treatment and prevention of bacterial infections like strep throat, urinary tract infections and tuberculosis. They may either completely kill or inhibit the growth of bacteria. Few antibiotics also possess antiprotozoal activity. Antibiotics are not effective against viral diseases such as the common cold or influenza and their inappropriate may allow the emergence of resistant organisms.

Track 9: Pneumococci and Pneumococcal Diseases

pneumococcal infection is an infection caused by the bacterium Streptococcus pneumoniae, which is also called the pneumococcus. S. pneumoniae is a common member of the bacterial flora colonizing the nose and throat of 5–10% of healthy adults and 20–40% of healthy children. However, it is also a cause of significant disease, being a leading cause of pneumonia, bacterial meningitis, and sepsis. The World Health Organization estimate that in 2005 pneumococcal infections were responsible for the death of 1.6 million children worldwide.

Track 10: Clinical Microbiology and Infectious Diseases

Clinical microbiology, the large subset of microbiology that is applied to medicine, is a branch of medical science concerned with the prevention, diagnosis and treatment of infectious diseases. In addition, this field of science studies various clinical applications of microbes for the improvement of health. There are four kinds of microorganisms that cause infectious disease: bacteria, fungi, parasites and viruses, and one type of infectious protein called prion.

Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Sponsors/Exhibitors

A huge thanks to all our amazing partners. We couldn’t have a conference without you!